RNP Antibodies

Other names: Antibodies to ribonucleoprotein, RNP ANTIBODY

Optimal result: 0 – 0.9 AI

Elevated RNP antibodies are most commonly associated with mixed connective tissue disease (MCTD), an autoimmune disorder that may present symptoms similar to those of systemic lupus erythematosus, scleroderma, and polymyositis. While the presence of high levels of RNP antibodies is a key diagnostic criterion for MCTD, it's important to note that these antibodies can also be found in other autoimmune disorders such as systemic lupus erythematosus (SLE) and sometimes in other rheumatic conditions. Their presence alone is not definitive for any one disease but must be interpreted in the context of symptoms, clinical findings, and other laboratory tests. It's also possible for RNP antibodies to be present in low titers in individuals without any autoimmune disorder.

In other diseases, anti-RNP antibodies are frequently associated with antibodies to Sm proteins. Antibody to RNP and Sm antigen are found in around 20-30% of patients with SLE. 20-25% of patients with progressive systemic sclerosis have anti-RNP. They are also found in other connective tissue diseases including a small <1% minority of patients with Sjögrens syndrome or rheumatoid arthritis. Anti-Sm is seldom found alone.

Antibodies to ribonucleoprotein, RNP, are found often in very high levels in patients with a variety of systemic rheumatic diseases, including SLE, progressive systemic sclerosis and Mixed Connective Tissue Disease, a distinct disease entity with overlapping clinical features of SLE, scleroderma, polymyositis and rheumatoid arthritis.

These autoantibodies usually give a strong speckled pattern of nuclear staining in immunofluorescence. The structure of the antigens recognised by anti-RNP antibodies is complex. The commonest determinants and ones which are most widely detected are those called RNP or U1RNP. Anti-RNP antibodies can be detected alone (usually in MCTD) or together with anti-Sm (lupus). Anti-Sm is seldom found alone.

Antibodies to ribonucleoprotein, RNP, are found often in very high levels in patients with a variety of systemic rheumatic diseases, including SLE, progressive systemic sclerosis and Mixed Connective Tissue Disease, a distinct disease entity with overlapping clinical features of SLE, scleroderma, polymyositis and rheumatoid arthritis.

These autoantibodies usually give a strong speckled pattern of nuclear staining in immunofluorescence. The structure of the antigens recognised by anti-RNP antibodies is complex. The commonest determinants and ones which are most widely detected are those called RNP or U1RNP. Anti-RNP antibodies can be detected alone (usually in MCTD) or together with anti-Sm (lupus). Anti-Sm is seldom found alone.

What is mixed connective tissue disease?

Mixed Connective Tissue Disease (MCTD) is a complex autoimmune disorder characterized by symptoms that overlap with several other connective tissue diseases, such as systemic lupus erythematosus, scleroderma, and polymyositis. Individuals with MCTD may experience a wide range of symptoms including joint pain, swelling, muscle weakness, Raynaud's phenomenon (a condition where fingers and toes change color and may become painful in response to cold temperatures or stress), and skin and internal organ involvement. The disease can vary greatly in its presentation and severity, and its management typically involves treatments that suppress the immune system to reduce inflammation and control symptoms. The course of MCTD can be unpredictable; some patients may experience a mild form, while others may have a more progressive and severe disease.

RNP Antibodies
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond RNP Antibodies — 10,000+ markers explained
One RNP Antibodies result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro